Device / Technology News

RSS

APN forms GPO partnership with ASDS

Aesyntix Physician Network (APN), a group purchasing organization (GPO) for dermatology and cosmetic surgery practices, and the American Society for Dermatologic Surgery (ASDS) today announced they have formed a partnership to provide ASDS members with significant savings opportunities on commonly purchased medical/surgical supplies and other products and services, including Revenue Cycle Management solutions.

17 Mar 2012

BC BS of Florida retires negative medical policy for FeNO testing

Aerocrine AB announces that BlueCross BlueShield (BC BS) of Florida1 has retired/archived their negative medical policy for FeNO testing. The change is effective March 15, 2012.

17 Mar 2012

SBMT announces 2012 recipients of Pioneers in Medicine, Technology and Healthcare Policy Awards

Today, the Society for Brain Mapping & Therapeutics announced the 2012 recipients of the organization's prestigious Pioneers in Medicine, Technology, and Healthcare Policy Awards.

17 Mar 2012

DMEI chooses ifa EMR v6 as future Electronic Medical Record system

ifa united i-tech, a U.S. subsidiary of ifa Systems AG, the global leader for IT solutions in ophthalmology, announced that the Dean McGee Eye Institute (DMEI) selected ifa EMR v6 as its future Electronic Medical Record (EMR) system.

17 Mar 2012

Researchers use standard inkjet printer to print live cells

Researchers from Clemson University have found a way to create temporary holes in the membranes of live cells using a standard inkjet printer. The method will be published in JoVE, the Journal of Visualized Experiments, on March 16.

17 Mar 2012

Kensey Nash to resolve Angio-Seal license disputes with St. Jude Medical

Kensey Nash Corporation today announced that the Company has entered into a settlement agreement with St. Jude Medical which resolves all disputes between the two companies relating to the Angio-Seal vascular closure device licenses, as well as other related claims.

17 Mar 2012

Researchers describe preparation of chitosan nanoparticles

Nanoparticles containing chitosan have been shown to have effective antimicrobial activity against Staphylococcus saprophyticus and Escherichia coli. The materials could be used as a protective wound-healing material to avoid opportunistic infection as well as working to facilitate wound healing.

17 Mar 2012

PFO closure device no better than drugs alone in preventing recurrent strokes or TIAs

Loyola University Medical Center is one of the major enrollers in a landmark clinical trial that found that plugging a hole in the heart works no better than drugs in preventing strokes.

17 Mar 2012

LCA comments on CDC's new anti-tobacco campaign

Today, Lung Cancer Alliance (LCA) said that the new anti-tobacco campaign just launched by the Centers for Disease Control and Prevention (CDC) is an important revitalization of the efforts to prevent young people from smoking and encourage all who do smoke to quit.

17 Mar 2012

Results from AspenBio Pharma's AppyScore trial on appendicitis to be presented at SAEM meeting

The results from AspenBio Pharma's 503-patient pilot study of AppyScore will be presented from the podium the upcoming West Region meeting of the Society for Academic Emergency Medicine (SAEM) being held in Las Vegas, March 16-17.

17 Mar 2012

The Medical Letter introduces mobile apps for iPad, Android

The Medical Letter – recognized since 1959 as the most trusted source of unbiased prescription drug information and drug facts - announces the launch of its mobile apps for iPad, iPhone, iPod Touch and Android.

17 Mar 2012

Solos to introduce new endoscopic instrument line, SteriTAP

Solos Endoscopy, Inc. is pleased to announce that the Company will be launching a new endoscopic instrument line, SteriTAP.

17 Mar 2012

UAB researchers develop new vehicle to release proteins with therapeutic effects

UAB researchers developed a new vehicle to release proteins with therapeutic effects. The vehicles are known as "bacteria inclusion bodies", stable insoluble nanoparticles which are found normally in recombinant bacteria.

17 Mar 2012

New book on reproductive treatments

In Vitro Fertilization [IVF] and the related technologies of assisted reproduction are no longer experimental procedures. In some European countries as many as 4% of all babies born are conceived by IVF, and in every kindergarten classroom there will no doubt be at least one IVF child. Assisted reproduction is the solution to today's epidemic of infertility.

17 Mar 2012

Thermo Fisher launches HyCell CHO medium

Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific HyCell CHO cell-culture medium, a versatile animal-derived- component-free (ADCF) and chemically defined (CD) medium for culturing a broad variety of CHO cells.

From Thermo Fisher Scientific Inc. 17 Mar 2012

Guidelines for cervical cancer screening revised

The guidelines say that women between 30 and 65 can wait five years between screenings if they get both a Pap test and an HPV test.

16 Mar 2012

Novel sensor selectively screens single molecules passing through nanopores

A novel type of sensor, based on nanometer-scale pores in a semiconductor membrane, is a step closer to practical use in applications such as analyzing the protein contents of a single cell. Researchers pioneering single-molecule nanopore sensor technology at the Technische Universit-t M-nchen (TUM) have shown its potential through a succession of experiments over the past few years.

16 Mar 2012

Experts highlight latest advances in use of biomarkers in various diseases

Over the last few decades there has been an explosion in the discovery of biomarkers for diagnosis, disease monitoring, and prognostic evaluation. In the April issue of Translational Research, entitled "Biomarkers: New Tools of Modern Medicine," an international group of medical experts explores the promise and challenges of biomarker discovery and highlights the latest advances in the use of biomarkers in various diseases.

16 Mar 2012

CYFRA reliable marker for response to chemotherapy for NSCLC

Researchers found that CYFRA and change in levels of CYFRA were found to be reliable markers for response to chemotherapy for non-small cell lung cancer (NSCLC) in a study of 88 patients. Research presented in the April 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology shows that this marker can be used to determine whether or not a patient should continue a particular chemotherapy regimen.

16 Mar 2012

Depression increases risk of death in PCI patients

Depression increases the risk of death in patients who have a coronary stent implanted. After seven years of follow up, depressed patients were 1.5 times more likely to have died than non-depressed patients. The findings were independent of age, gender, clinical characteristics, anxiety and the distressed (Type D) personality.

16 Mar 2012